Benefits of higher doses of certain medicines fail to justify costs and risks, study shows

Wednesday, May 6, 2020 - 13:50 in Health & Medicine

Clinical trial data behind drug dose recommendations for elevated cholesterol and chronic obstructive pulmonary disease illustrate how larger doses may not be worth the extra costs for many types of patients, according to an Oregon State University College of Pharmacy researcher. The findings, published in the Journal of American Biomedical Science & Research, point out […]

Read the whole article on Science Blog

More from Science Blog

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net